Monocarboxylate Transporter-1 Is Dispensable for Hepatocellular Carcinoma Development. [PDF]
ABSTRACTHepatocellular carcinoma (HCC) is the most prevalent type of liver cancer and the deadliest liver disease. It is imperative to understand the underlying molecular mechanisms involved in the development of HCC. Monocarboxylate transporter‐1 (MCT1) is a proton‐coupled protein that facilitates the bidirectional transport of monocarboxylates, such ...
Gad SA +4 more
europepmc +3 more sources
Monocarboxylate Transporters 1 and 4 and MTCO1 in Gastric Cancer [PDF]
Background: Monocarboxylate transporters (MCTs) appear to play an important role in tumor development and aggressiveness. The present study aimed to evaluate associations between cytoplasmic MCT1, MCT4, and mitochondrial cytochrome c oxidase (MTCO1) expression and clinicopathological variables or survival in gastric cancer.
Kauppila Joonas +2 more
openaire +3 more sources
Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965. [PDF]
The monocarboxylate transporter 1 (MCT1) is a key element in tumor cell metabolism and inhibition of MCT1 with AZD3965 is undergoing clinical trials. We aimed to investigate nutrient fluxes associated with MCT1 inhibition by AZD3965 to identify possible biomarkers of drug action.
Braga M +16 more
europepmc +6 more sources
Background Amyotrophic lateral sclerosis (ALS) is a devasting neurodegenerative disorder for which no successful therapeutics are available. Valproic acid (VPA), a monocarboxylate derivative, is a known antiepileptic drug and a histone deacetylase ...
Asmita Gyawali +5 more
doaj +1 more source
Creatineおよび creatine 前駆体の排出輸送におけるmonocarboxylate transporter 12の役割解明 [PDF]
富山大学博士(薬科学)Article富山大学・富医薬博甲第425号・定村 龍太・2023/03/23 公表論文 1.Jomura R, Tanno Y, Akanuma SI, Kubo Y, Tachikawa M, Hosoya KI. Monocarboxylate transporter 12 as a guanidinoacetate efflux transporter in renal proximal tubular epithelial cells. Biochim Biophys
定村, 龍太
core +1 more source
Inhibition of monocarboxylate transporter 1 has been proposed as a therapeutic approach to perturb lactate shuttling in tumor cells that lack monocarboxylate transporter 4.
Richard A. Noble +16 more
doaj +1 more source
Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
The pathogenesis and refractory nature of inflammatory bowel disease (IBD) are related to multiple factors, including genetic factors, environmental factors, and abnormalities in gut microbial diversity, which lead to decreased levels of short-chain ...
Shinji Ota, Hirotake Sakuraba
doaj +1 more source
Monocarboxylate transporter 8 modulates the viability and invasive capacity of human placental cells and fetoplacental growth in mice [PDF]
Monocarboxylate transporter 8 (MCT8) is a well-established thyroid hormone (TH) transporter. In humans, MCT8 mutations result in changes in circulating TH concentrations and X-linked severe global neurodevelopmental delay.
Laurence S Loubière +83 more
core +1 more source
Structure and function of a monocarboxylate transporter homolog specific for L-lactate. [PDF]
Monocarboxylate transporters play important roles in certain cancers. We have reported structures of an L-lactate-transporting solute carrier family 16 homolog with bound substrate and inhibitor.
Dimitrios Fotiadis +11 more
core +2 more sources
Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat [PDF]
PURPOSE.
Layton, Christopher J. +5 more
core +1 more source

